23andMe made a name for itself selling DNA test kits, but today it announced a radical new direction: The company will start mining its huge database of DNA sequences to create new drugs. The science of how they could do that is fascinating—but it raises a lot of futuristic ethical questions too.
Misha Angrist is an assistant professor at Duke who specializes in personal genomics. He deals with questions such as what having all our personal genetic information just a mailbox away means, and just who owns your genetic information. He's here today to answer all your questions about personal genetics.